Pharma5: Coming Soon — Rx Price Relief?
Americans spend more on prescription drugs than any other developed country, but new federal initiatives aim to make medicine more affordable.
Heart Disease: A Patient’s Perspective
Heather Bardeleben’s symptoms didn’t fit the textbook definition of heart disease, and her delayed diagnosis nearly cost her her life..
Heart Disease: A Physician’s Perspective
An interview with Dr. Nancy Sweitzer, an internationally recognized cardiologist, physician-scientist and clinical researcher who specializes in heart failure and transplant cardiology.
Keeping the Pulse on the Plasma Industry: A Conversation with Jorey Berry, President and CEO of the Immune Deficiency Foundation
President and CEO of the Immune Deficiency Foundation, Jorey Berry, discusses the challenges and opportunities in the plasma industry.
New Therapies Show Promise for Treating Critical Illnesses
An in-depth look at burgeoning therapeutic methods poised to change the way physicians treat key critical illnesses
Vasculitis: On the Road to Recovery
When a rare disease nearly sidelined Andrew Green, off-label use of immune globulin restored his health and inspired him to become an advocate for patients facing similar challenges
PMDD: A Physician’s Perspective
David R. Rubinow, MD, professor and chair of psychiatry at the University of North Carolina School of Medicine and founding director of the UNC Center for Women’s Mood Disorders, has focused extensively on conditions like premenstrual dysphoric disorder.
PMDD: A Patient’s Perspective
Sarah Gillespie lived under the shadow of a condition called premenstrual dysphoricdisorder, or PMDD for six long, difficult years.
Pharma5: Five Challenges of Implementing AI
Artificial intelligence is poised to change the practice of medicine and improve patient outcomes, but challenges remain.
Artificial Intelligence in Healthcare Moves from New to Normal
This issue of BioSupply Trends Quarterly explores artificial intelligence, advancements in cardiac care and value-based care.